Skip to main content

Table 5 Improvement in QOL scores between baseline, EOT, and SVR12

From: Impact of treating chronic hepatitis C with direct acting antivirals on health-related quality of life: a real-life Egyptian experience

QoL dimension

(n = 399)

% with better QoL at EoT, at SVR12 (n)

Mean QoL score (0–100)

Mean difference

95% CI

P value

Physical health

 Baseline

 

75.2

   

 EoT

45 (179)

79.5

9.5

7.2, 11.7

< 0.0001

 SVR-12

62 (248)

89

13.8

11.3, 16.2

< 0.0001

Emotional health

 Baseline

 

84.3

   

 EoT

48 (190)

90.4

6.1

3.8, 8.4

< 0.0001

 SVR-12

54 (218)

96.2

11.8

9.7, 13.9

< 0.0001

 Missing

1

    

Future uncertainty

 Baseline

 

77.5

   

 EoT

54 (216)

85.3

7.8

5.4, 10.2

< 0.0001

 SVR-12

64 (255)

91.4

13.9

11.6, 16.2

< 0.0001

 Missing

1

    

Intimate relation

 Baseline

 

88.5

   

 EoT

25 (97)

93.5

5.1

2.8, 7.3

< 0.0001

 SVR-12

28 (112)

97.1

8.6

6.4, 10.9

< 0.0001

 Missing

12

    

Social health

 Baseline

 

68.2

   

 EoT

31 (117)

70.1

2.6

0.7, 4.5

< 0.01

 SVR-12

32 (126)

71.7

3.6

1.6, 5.5

< 0.001

 Missing

12

    

Cognitive function

 Baseline

 

87.9

   

 EoT

26 (98)

90.4

2.4

0.2, 4.7

< 0.05

 SVR-12

29 (114)

92.6

4.7

2.5, 6.9

< 0.0001

 Missing

19

   Â